Who We Serve: Clinical Area
Ophthalmic Devices
Ophthalmic products work in a small, unforgiving space. Optical tolerances are tight, residues that would be harmless elsewhere can injure the eye, and some products are worn daily by consumers rather than handled by clinicians. We help ophthalmic manufacturers find the gaps those conditions expose.
Standards and Regulations to Know
- 21 CFR Part 820 (QMSR)Quality Management System Regulation
- 21 CFR Part 814Premarket Approval
- ISO 14971Risk Management for Medical Devices
- ISO 10993-1Biological Evaluation Within a Risk Management Process
- ISO 17665Moist Heat Sterilization
- ISO 11607Packaging for Terminally Sterilized Medical Devices
- IEC 60601-1Basic Safety and Essential Performance of Medical Electrical Equipment
- 21 CFR Part 803Medical Device Reporting
Typical Regulatory Exposure
The category includes contact lenses and lens care products, intraocular lenses, viscoelastic and other surgical products, ophthalmic lasers and diagnostic instruments. Intraocular lenses and some other products are Class III and reach the market through PMA, while many instruments and some contact lenses are Class II. One firm can face a pre-approval inspection for one product line and routine surveillance for another.
Products that contact the inside of the eye carry particular concern for residues and endotoxins, because inflammation after intraocular surgery has been linked to contamination of devices and instruments. Cleaning validation, endotoxin control and reprocessing instructions for intraocular instruments are recurring audit topics, and biological evaluation under the ISO 10993 series has to account for ocular contact.
Optical performance is measured, not observed, so the measurement systems themselves need to be validated. Lens products packaged in solution depend on sterilization, package integrity and stability data that hold for the labeled shelf life, and consumer-facing products generate complaint volumes and reporting decisions that look more like consumer goods than surgical devices.
Where Audits Find Gaps
- 01
Optical Test Methods Not Validated
Power, resolution and other optical measurements are used for release, but the test methods and gauges have no documented measurement system analysis or validation.
- 02
Residue and Endotoxin Limits Without Rationale
Acceptance limits for residues or endotoxins on intraocular products were set by habit, with no documented basis tied to the product's contact and risk.
- 03
Consumer Complaints Split Across Channels
Complaints from wearers, eye care practitioners and retailers arrive through different channels and are never consolidated or trended together.
- 04
Shelf Life Based on an Earlier Package
Shelf-life claims for lenses packaged in solution rely on stability data for an earlier package or solution formulation.
- 05
Instrument Service Data Outside the Risk File
Servicing and calibration records for lasers and diagnostic instruments sit with field service, outside complaint review and risk management.
Relevant Standards and Regulations
- 21 CFR Part 820 (QMSR)Quality Management System Regulation
- 21 CFR Part 814Premarket Approval
- ISO 14971Risk Management for Medical Devices
- ISO 10993-1Biological Evaluation Within a Risk Management Process
- ISO 17665Moist Heat Sterilization
- ISO 11607Packaging for Terminally Sterilized Medical Devices
- IEC 60601-1Basic Safety and Essential Performance of Medical Electrical Equipment
- 21 CFR Part 803Medical Device Reporting
Relevant Services
AI-Assisted QMS Gap Assessment
An AI-assisted first pass over the QMS documents you already have, with every result reviewed by an advisor.
PMA Pre-Approval Inspection Preparation
Getting Class III manufacturers ready for the facility inspection that accompanies PMA review.
FDA Inspection Readiness (CP 7382.850)
FDA device inspection preparation built around Compliance Program 7382.850 and its risk-based approach.
CAPA System Remediation
Fixing a CAPA system auditors keep citing: the procedure, the records, root cause, effectiveness and backlog.
Audits and Inspections You May Face
FDA PMA Pre-Approval Inspection
An FDA inspection tied to a PMA application that checks your quality system and its match to the submission.
FDA Baseline Surveillance Inspection
FDA's comprehensive surveillance inspection of your quality system under Compliance Program 7382.850.
ISO 13485 Surveillance Audit
The periodic audits, at least annually, that support continued ISO 13485 certification between renewals.
Questions
Why do auditors focus on residues for intraocular products?
Because inflammation after intraocular surgery has been associated with contamination such as endotoxins and cleaning residues on products and instruments. Auditors expect validated cleaning, justified limits and routine monitoring, plus reprocessing instructions that address residue removal for reusable intraocular instruments.
We make both PMA and 510(k) ophthalmic products. Should the QMS treat them differently?
It is one quality system, but the change decisions differ. A change to a PMA product needs an evaluation against PMA supplement requirements, while a change to a 510(k) product needs an evaluation of whether a new submission is required, so each change record should state which products it affects.
How should we handle complaints from practitioners and retailers?
Treat every channel as a complaint source and define how each one reaches the complaint file. Then trend them together, since a problem may surface first in practitioner reports and only later in consumer complaints.
Ophthalmic Devices
Get an Advisor's View of Your Quality System
Tell us about your devices and the audit or inspection ahead, and an advisor will scope an assessment for your kind of product. Please don't send confidential documents yet: secure upload is set up after onboarding.
